RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
-
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer.
Authors: Mara H Rendi, Nanjoo Suh, William W Lamph, Stan Krajewski, John C Reed, Richard A Heyman, Andrew Berchuck, Karen Liby, Renee Risingsong, Darlene B Royce,…
Cancer research 2004 May 15 -
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
Authors: Karen Liby, Candice C Black, Darlene B Royce, Charlotte R Williams, Renee Risingsong, Mark M Yore, Xi Liu, Tadashi Honda, Gordon W Gribble, William W Lamph,…
Molecular cancer therapeutics 2008 May
Thought leaders and organizations working on research involving lg100268.
- Dartmouth Medical School
- Kyushu University
- University of Texas Southwestern Medical Center
- University of Texas M. D. Anderson Cancer Center
- Taussig Cancer Center
Community
